BLACK WEEKSFlakoni −15% · komplekti −10% · pārējais −5%ar koduBezmaksas piegāde Vācijā no €200

Šī lapa ir tulkota automātiski un var saturēt kļūdas. Vai latviešu valoda ir jūsu dzimtā valoda? Mēs labprāt saņemsim jūsu atsauksmes un labojumus.Sūtīt atsauksmi

The Peptide Desk The Peptide Desk
GHK-Cu + KPV Blend, produkta foto

Laboratorijas ziņojums

PDF
99%
Tīrība
Pārbaudīts
GHK-Cu + KPV Blend 60mg
Laboratorija
Analiza Białek
Datums
October 2026
Rezultāts
99% purity (GHK-Cu 95.54 mg + KPV 10.91 mg, 50 + 10 mg label)
Endotoksīni
6.88 EU/vial
Pasūtījuma nr.
Parole

Neatkarīgi pārbaudīts, ar paroli pārbaudāms tieši laboratorijā.

Healing

GHK-Cu + KPV Blend

Healing

Pasūtījums

Vienības cena - Bezmaksas piegāde Vācijā no 200 € Black Weeks laikā
  • DHL ar izsekošanu
  • Diskrēts iepakojums

4.6 no 5 Trustpilot73 atsauksmes

Zināšanas

Viss par GHK-Cu + KPV Blend

Detalizēta informācija drīzumā.

Noderēs

Kas jums vēl būs vajadzīgs

Bakteriostatiskais ūdens tiek automātiski pievienots grozam. Šļirces un salvetes - ar vienu klikšķi.

Insulīna šļirces

10 gab. · 5.50 €

Spirta salvetes

50 gab. · 10 €

Cik daudz ūdens?

Vienības uz šļirces jūsu flakona izmēram.

Atvērt kalkulatoru →

FAQ

Bieži uzdotie jautājumi

Avoti katrai atbildei: leksikona ieraksts

Vēl ir jautājums?

Rakstiet mums, mūsu komanda jums palīdzēs.

Are there studies on the GHK-Cu + KPV Blend?

No. As of 26 October 2026 there is no study on the blend, neither on ClinicalTrials.gov nor in PubMed. The only paper naming both peptides is a review of tripeptides in wound healing without its own data on the blend. Only the single components have been studied.

Why these two peptides?

The idea is that the pathways complement each other: GHK-Cu on the side of building and collagen, KPV on the side of calming inflammation. This has not been tested. No study has examined whether the combination does more than either substance alone.

What is known about GHK-Cu in humans?

The best study is a randomised gel trial in diabetic foot ulcers: a median 98.5 percent of the wound area closed, versus 60.8 percent with vehicle gel. Other data come mainly from cosmetics. A recent review calls the clinical evidence sparse, there are no studies on injection.

What is known about KPV?

KPV enters gut and immune cells via the transporter PepT1 and inhibits the inflammation pathway NF-κB there even at nanomolar concentrations. In two colitis models in mice KPV in the drinking water reduced inflammation. In nanoparticles a 12,000-fold lower concentration was enough. In skin cells KPV triggered a calcium signal. There are no human studies.

Which side effects are known?

There are no data for the blend. In the GHK-Cu gel trial 7 percent of ulcers became infected, versus 34 percent with vehicle gel. Human safety data are missing for KPV and for GHK-Cu as an injection. A review of peptides in sport warns that robust safety data are missing for many of these substances.

Is the blend approved?

No. Neither the blend nor GHK-Cu or KPV is approved as a medicine (as of October 2026). ChEMBL lists GHK without a clinical phase and no trial of KPV is registered.

Saistītie

Saistītie produkti